Barbara Kraus, PhD Takeda

With more than 20 years of experience in the biopharmaceutical industry Barbara´s particular expertise lies in the field of cell line & cell culture medium development, the development of upstream and separation processes, scale up and process transfer to clinical pilot plants and industrial manufacturing plants for recombinant proteins, viral vaccines and vectors as AAV.

Currently, Barbara holds the position "Director, Head of Gene Therapy Tech & Sciences”.

She earned her PhD in Biotechnology at the University of Natural Resources and Life Sciences, Vienna, Austria.